ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Minaris Will Be the Commercial Manufacturer in Europe for Skysona™, bluebird bio’s Gene Therapy for CALD
July 22, 2021Minaris Regenerative Medicine GmbH (“Minaris”), a leading contract development and manufacturing organization (CDMO) for the cell and gene therapy industry, will be the commercial manufacturer in Europe for Skysona™ (elivaldogene autotemcel, Lenti-D™), a -
CHMP puts eight new medicines forward for EU approval
May 25, 2021An investigational pneumococcal conjugate vaccine (PCV) candidate, developed by MSD, has achieved positive topline results in a Phase III paediatric study. -
bluebird bio releases new data on its gene therapy for cerebral adrenoleukodystrophy
March 17, 2021Data from nearly seven years of follow up suggests one-time treatment with eli-cel may durably stabilise cerebral adrenoleukodystrophy disease progression.
Pharma Sources Insight January 2025
